Executive Advisory Board
The CLP Executive Advisory Board (EAB) is integral to the growth and success of the Institute. Founded in 2005, the Board includes business leaders, entrepreneurs, researchers, physicians and tech experts. The EAB provides members with a gateway to the world of transdisciplinary biomedical discovery, innovation and education. Board members contribute their individual strengths to the Institute in the form of business advice and assistance in commercializing innovations, insight into educational programs, feedback on operations, strategic plans, marketing, fundraising, and individual philanthropy.
James Basta
Executive Vice President, General Counsel and Corporate Secretary, Intellia Therapeutics
Adam Bergstein
Founder and Managing Member, Patent Protection Research, Inc.
Brian Bernick, MD
Chairman of the Board, Micron Biomedical, Inc.
Michael Boyne, II
Co-founder and Principal, CatalystBio
Joel B. Braunstein
Co-Founder, President and Chief Operating Officer, C2N Diagnostics
Michael Brown
Chairman and Chief Operating Officer Euronet Worldwide, Inc.
Andrew Chan
Senior Vice President of Research Biology, Genentech, Inc.
John Chen
Vice Chairman and Chief Operating Officer, Hilco Global
Stuart Cornew
Managing Director, AnswerMine
Steven Deitcher
Founder, Chief Operating Officer and Chairman, Bespoke Biotherapeutics, LLC
Timothy K. Krauskopf
Principal, Round Lake Designs, LLC
Patrick Martin
Managing Director, Principal, Martin Investment Management, LLC
Mani Mohindru
Co-Founder; Roshon Therapeutics (stealth)
Christopher J. O’Connell
Corporate Director and Advisor
Michael O’Shea
Founder, The O’Shea Firm
Chandler Robinson
Chief Operating Officer, Monopar Therapeutics
Myung K. Shin
Vice President, Head of Early Discovery Translation & In Vitro Pharmacology, Kallyope, Inc.
Ulrich Thienel
President, UT Partners, LLC
Tracy Ward
Principal, Schwartz Capital Group
